arrow_back Back to App

Biomedical Innovation Fund: Boosting Medical Research and Development

This act establishes a dedicated fund to annually support medical research by the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). The goal is to accelerate the development of new drugs, therapies, and diagnostic methods, potentially improving citizens' health and quality of life. These funds will target diseases that heavily burden the healthcare system and support emerging scientists.
Key points
A Biomedical Innovation Fund is established, receiving $10 billion annually until 2031 for medical research.
Funds will be distributed to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) to advance new treatments and diagnostics.
The fund aims to support research into chronic diseases, conditions affecting older individuals, and innovative treatment approaches, including those for chronic pain.
A portion of the funds will be allocated to support early career scientists and promote diversity within research communities.
Distribution of funds is contingent on NIH and FDA maintaining specific levels of discretionary appropriations from the federal budget.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_4124
Sponsor: Rep. Clarke, Yvette D. [D-NY-9]
Process start date: 2021-06-24
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

National Biomedical Research Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_4124.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-06-24.

What are the main provisions?

Key points include:

  • A Biomedical Innovation Fund is established, receiving $10 billion annually until 2031 for medical research.
  • Funds will be distributed to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) to advance new treatments and diagnostics.
  • The fund aims to support research into chronic diseases, conditions affecting older individuals, and innovative treatment approaches, including those for chronic pain.
  • A portion of the funds will be allocated to support early career scientists and promote diversity within research communities.
  • Distribution of funds is contingent on NIH and FDA maintaining specific levels of discretionary appropriations from the federal budget.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Clarke, Yvette D. [D-NY-9].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

CATEGORIES

Health Public Investments